Sign in

CIK 0002019410

  • Non-accelerated filer
  • Emerging growth company

Caris Life Sciences, Inc.

Sign in to watch
Ticker
CAI
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
TX
Entity type
Operating
EIN
852077369
Phone
+1 866-771-8946
Business address
750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
  1. 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
  2. 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
  3. 4 Grant or award President acquired 83,162 shares (grant or award)
  4. 4 Grant or award See Remarks acquired 83,162 shares (grant or award)
  5. 4 Grant or award See Remarks acquired 320,112 shares (grant or award)
  6. 4 Grant or award Director acquired 2,492 shares (grant or award)
  7. 4 Grant or award Director acquired 2,492 shares (grant or award)
  8. 4 Grant or award Director acquired 2,492 shares (grant or award)
  9. 4 Grant or award Director acquired 2,492 shares (grant or award)
  10. 4 Grant or award Director acquired 3,739 shares (grant or award)
  11. 4 Grant or award Director acquired 5,509 shares (grant or award)
  12. 4 Option exercise Director acquired 2,500 shares (option exercise)
  13. 4 Planned sale See Remarks sold 62,250 shares at an average $26.58 ($1,654,461)
  14. 4 Gift See Remarks gave 1,300 shares (gift)
  15. 4 Open-market buy See Remarks bought 4,184 shares at $24.09 ($100,793)
  16. 4 Open-market buy President bought 400 shares at $23.85 ($9,540)
  17. 4 Option exercise Director acquired 100,000 shares (option exercise)
  18. 4 Shares withheld for taxes Director gave up 139,517 shares (to pay taxes)
  19. 4 Shares withheld for taxes President gave up 63,509 shares (to pay taxes)
  20. 4 Shares withheld for taxes See Remarks gave up 141,956 shares (to pay taxes)

Page 2 of 4 · 67 filings